BioLineRx Market Cap

BioLineRx has a market cap or net worth of 53.71 million as of August 14, 2025. Its market cap has decreased by -76.55% in one year.

Market Cap

53.71M

Enterprise Value

6.69M

Revenue

58.12M

Ranking

n/a

PE Ratio

n/a

Stock Price

2.10

Market Cap Chart

Since February 13, 2007, BioLineRx's market cap has increased from 163.03K to 53.71M, an increase of 32,845.77%. That is a compound annual growth rate of 36.78%.

Market Cap History

Date	Market Cap	% Change
Aug 13, 2025	53.71M	-37.22%
Dec 31, 2024	85.55M	-79.39%
Dec 31, 2023	415.08M	314.57%
Dec 29, 2022	100.12M	-67.59%
Dec 30, 2021	308.95M	60.58%
Dec 31, 2020	192.39M	108.80%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 31, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Teva Pharmaceutical Industries	65.08B
Danel (Adir Yeoshua)	2.52B
Kamada	1.46B
Bait Bakfar	1.06B
SofWave Medical	980.58M
BrainsWay	788.52M
Novolog (Pharm-Up 1966)	709.61M
Ilex Medical	673.41M

Market Cap Rankings